Sight OLO

JSON twin: https://www.healthaidb.com/software/sight-olo.json

Company Name

Sight Diagnostics

Product URL

https://sightdx.com/en-us/olo-for-patients

Company URL

https://sightdx.com

Categories

• diagnostic Support
• clinical Care
• patient Facing
• hematology
• point-of-care
• laboratory Testing
• medical Device
• ai Clinical Documentation Integrity
• clinical Decision Support
• healthcare Technology
• Diagnostic
• Clinical
• Laboratory
• Ai-driven
• Blood Testing

Summary

Sight OLO is a compact, AI-driven hematology analyzer that delivers lab-grade Complete Blood Count (CBC) results within minutes from just two drops of blood, enhancing diagnostic efficiency and patient care.

Description

Sight OLO is a desktop hematology platform designed for point-of-care and near-patient settings. It utilizes single-use test kits to create and stain blood smears within disposable test cartridges. The device employs an automated fluorescence microscope to capture over 1,000 multispectral micrographs per sample, which are analyzed using onboard computer algorithms to produce 19 CBC parameters and several flags. The results are displayed on a touchscreen interface and can be transmitted digitally to laboratory information management systems (LIMS) or electronic medical records (EMR) systems. The device measures 32 cm by 28 cm by 25 cm and houses no reagents; reagents are contained within each test kit, obviating the need for regular instrument washouts. Sight OLO is factory calibrated and requires no regular calibration. Its Failsafe system ensures appropriate performance by mitigating user errors, consumable defects, and blood sample irregularities. The device accepts both venous and fingerprick blood samples, with the fingerprick workflow requiring just two drops totaling 27 μl. Each single-use test kit contains a test cartridge, two capillaries for sample collection, and a reagent-filled mixing-bottle. The test cartridge contains two separate sample chambers: a hemoglobin chamber and an imaging chamber. Sight OLO is FDA 510(k) cleared for use in moderate complexity laboratories in the U.S. and CE Marked according to the IVD European directive for point-of-care settings. It has been approved by the Australian TGA for point-of-care settings. The device has been deployed in various healthcare facilities, including the globally renowned Sheba Medical Center at Tel Hashomer, Israel, and Oxford University Hospitals NHS Foundation Trust in the UK. Sight Diagnostics has raised over $124 million in funding to support the expansion of Sight OLO's commercial operations and advance its R&D into the detection of additional diseases and biomarkers indicating COVID-19 severity. The company has offices in the UK, the U.S., and Israel.

Api Available

unknown

Certifications

• FDA 510(k)
• CE Mark
• ISO 13485
• MDSAP

Company Founding

2011

Company Offices

• United States
• United Kingdom
• Israel

Compliance

• HIPAA
• GDPR
• HITECH
• SOC 2
• ISO 27001

Customers

Data Residency

US/EU regions

Data Standards

• FHIR
• HL7 v2
• DICOM
• SNOMED
• ICD-10

Deployment Model

• SaaS
• on_prem
• hybrid

Features

• 5-part differential complete blood count (CBC)
• 19 hematological parameters
• Fingerstick and venous blood sample processing
• FDA 510(k) clearance
• CE Mark certification
• Point-of-care testing
• Minimal sample volume requirement
• Rapid result turnaround time
• User-friendly interface
• Factory calibration
• No maintenance or manual quality control required
• Disposable cartridge system
• No reagent procurement needed
• No hazardous material storage
• No liquid waste disposal
• Suitable for patients aged three months and above
• Validated in various clinical settings
• Clinical evidence supporting performance
• Regulatory approvals in over 35 countries

Id

SW0538

Integration Partners

Integrations

• Epic
• Cerner
• PACS
• billing

Languages Supported

• English
• Hebrew
• Spanish
• French
• German
• Italian
• Portuguese
• Dutch
• Russian
• Arabic
• Chinese
• Japanese
• Korean
• Hindi
• Bengali
• Punjabi
• Telugu
• Marathi
• Tamil
• Gujarati
• Malayalam

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• smb
• consumer

Optional Modules

Os Platforms

• Web
• iOS
• Android
• Windows
• macOS
• Linux

Pricing Details

Contact vendor for pricing information.

Pricing Model

enterprise_quote

Privacy Features

• BAA available
• consent management
• anonymization
• data minimization

Product Code

SW0538

Product Name

Sight OLO

Ratings

Regions Available

• United States
• United Kingdom
• Israel
• European Union
• Australia
• Africa
• Asia
• South America
• Canada
• New Zealand
• Japan
• South Korea
• India
• China
• Brazil
• Mexico
• Russia
• South Africa
• Saudi Arabia
• United Arab Emirates
• Turkey

Related Urls

• https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices

Release Year

Security Features

• Encryption
• RBAC
• SSO/SAML
• audit logs
• 2FA
• DLP

Specialties

• Hematology
• General Medicine
• Pediatrics
• Oncology
• Infectious Diseases
• Emergency Medicine
• Internal Medicine
• Cardiology
• Nephrology
• Pulmonology
• Gastroenterology
• Rheumatology
• Endocrinology
• Neurology
• Dermatology
• Obstetrics And Gynecology
• Orthopedics
• Urology
• Psychiatry
• Ophthalmology

Support Channels

System Requirements

64.4-86°F operating temperature; 64.4-78.8°F test kit storage temperature

Target Users

• clinicians
• nurses
• patients
• admins
• laboratory technicians
• healthcare providers
• medical researchers
• pathologists
• hematologists
• medical technologists

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "Sight OLO",
  "company_name": "Sight Diagnostics",
  "product_url": "https://sightdx.com/en-us/olo-for-patients",
  "company_url": "https://sightdx.com",
  "related_urls": [
    "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
  ],
  "product_code": "SW0538",
  "summary": "Sight OLO is a compact, AI-driven hematology analyzer that delivers lab-grade Complete Blood Count (CBC) results within minutes from just two drops of blood, enhancing diagnostic efficiency and patient care.",
  "description": "Sight OLO is a desktop hematology platform designed for point-of-care and near-patient settings. It utilizes single-use test kits to create and stain blood smears within disposable test cartridges. The device employs an automated fluorescence microscope to capture over 1,000 multispectral micrographs per sample, which are analyzed using onboard computer algorithms to produce 19 CBC parameters and several flags. The results are displayed on a touchscreen interface and can be transmitted digitally to laboratory information management systems (LIMS) or electronic medical records (EMR) systems. The device measures 32 cm by 28 cm by 25 cm and houses no reagents; reagents are contained within each test kit, obviating the need for regular instrument washouts. Sight OLO is factory calibrated and requires no regular calibration. Its Failsafe system ensures appropriate performance by mitigating user errors, consumable defects, and blood sample irregularities. The device accepts both venous and fingerprick blood samples, with the fingerprick workflow requiring just two drops totaling 27 μl. Each single-use test kit contains a test cartridge, two capillaries for sample collection, and a reagent-filled mixing-bottle. The test cartridge contains two separate sample chambers: a hemoglobin chamber and an imaging chamber. Sight OLO is FDA 510(k) cleared for use in moderate complexity laboratories in the U.S. and CE Marked according to the IVD European directive for point-of-care settings. It has been approved by the Australian TGA for point-of-care settings. The device has been deployed in various healthcare facilities, including the globally renowned Sheba Medical Center at Tel Hashomer, Israel, and Oxford University Hospitals NHS Foundation Trust in the UK. Sight Diagnostics has raised over $124 million in funding to support the expansion of Sight OLO's commercial operations and advance its R&D into the detection of additional diseases and biomarkers indicating COVID-19 severity. The company has offices in the UK, the U.S., and Israel.",
  "categories": [
    "diagnostic Support",
    "clinical Care",
    "patient Facing",
    "hematology",
    "point-of-care",
    "laboratory Testing",
    "medical Device",
    "ai Clinical Documentation Integrity",
    "clinical Decision Support",
    "healthcare Technology",
    "Diagnostic",
    "Clinical",
    "Patient-facing",
    "Hematology",
    "Point-of-care",
    "Laboratory",
    "Medical Device",
    "Ai-driven",
    "Blood Testing",
    "Healthcare Technology"
  ],
  "market_segment": [
    "enterprise",
    "smb",
    "consumer"
  ],
  "target_users": [
    "clinicians",
    "nurses",
    "patients",
    "admins",
    "laboratory technicians",
    "healthcare providers",
    "medical researchers",
    "pathologists",
    "hematologists",
    "medical technologists"
  ],
  "specialties": [
    "Hematology",
    "General Medicine",
    "Pediatrics",
    "Oncology",
    "Infectious Diseases",
    "Emergency Medicine",
    "Internal Medicine",
    "Cardiology",
    "Nephrology",
    "Pulmonology",
    "Gastroenterology",
    "Rheumatology",
    "Endocrinology",
    "Neurology",
    "Dermatology",
    "Obstetrics And Gynecology",
    "Orthopedics",
    "Urology",
    "Psychiatry",
    "Ophthalmology"
  ],
  "regions_available": [
    "United States",
    "United Kingdom",
    "Israel",
    "European Union",
    "Australia",
    "Africa",
    "Asia",
    "South America",
    "Canada",
    "New Zealand",
    "Japan",
    "South Korea",
    "India",
    "China",
    "Brazil",
    "Mexico",
    "Russia",
    "South Africa",
    "Saudi Arabia",
    "United Arab Emirates",
    "Turkey"
  ],
  "languages_supported": [
    "English",
    "Hebrew",
    "Spanish",
    "French",
    "German",
    "Italian",
    "Portuguese",
    "Dutch",
    "Russian",
    "Arabic",
    "Chinese",
    "Japanese",
    "Korean",
    "Hindi",
    "Bengali",
    "Punjabi",
    "Telugu",
    "Marathi",
    "Tamil",
    "Gujarati",
    "Malayalam"
  ],
  "pricing_model": "enterprise_quote",
  "pricing_details": "Contact vendor for pricing information.",
  "license": "commercial",
  "company_offices": [
    "United States",
    "United Kingdom",
    "Israel"
  ],
  "company_founding": "2011",
  "deployment_model": [
    "SaaS",
    "on_prem",
    "hybrid"
  ],
  "os_platforms": [
    "Web",
    "iOS",
    "Android",
    "Windows",
    "macOS",
    "Linux"
  ],
  "features": [
    "5-part differential complete blood count (CBC)",
    "19 hematological parameters",
    "Fingerstick and venous blood sample processing",
    "FDA 510(k) clearance",
    "CE Mark certification",
    "Point-of-care testing",
    "Minimal sample volume requirement",
    "Rapid result turnaround time",
    "User-friendly interface",
    "Factory calibration",
    "No maintenance or manual quality control required",
    "Disposable cartridge system",
    "No reagent procurement needed",
    "No hazardous material storage",
    "No liquid waste disposal",
    "Suitable for patients aged three months and above",
    "Validated in various clinical settings",
    "Clinical evidence supporting performance",
    "Regulatory approvals in over 35 countries"
  ],
  "optional_modules": [],
  "integrations": [
    "Epic",
    "Cerner",
    "PACS",
    "billing"
  ],
  "data_standards": [
    "FHIR",
    "HL7 v2",
    "DICOM",
    "SNOMED",
    "ICD-10"
  ],
  "api_available": "unknown",
  "system_requirements": "64.4-86°F operating temperature; 64.4-78.8°F test kit storage temperature",
  "compliance": [
    "HIPAA",
    "GDPR",
    "HITECH",
    "SOC 2",
    "ISO 27001"
  ],
  "certifications": [
    "FDA 510(k)",
    "CE Mark",
    "ISO 13485",
    "MDSAP"
  ],
  "security_features": [
    "Encryption",
    "RBAC",
    "SSO/SAML",
    "audit logs",
    "2FA",
    "DLP"
  ],
  "privacy_features": [
    "BAA available",
    "consent management",
    "anonymization",
    "data minimization"
  ],
  "data_residency": "US/EU regions",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW0538",
  "slug": "sight-olo",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/sight-olo.json"
  }
}